TY - JOUR
T1 - Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005
AU - Giannetti, A.
AU - Thestrup-Pedersen, K.
AU - Taïeb, Alain
AU - Hanifin, Jon
AU - Cooper, Kevin
AU - Bos, Jan D.
AU - Imokawa, Genji
AU - David, Tim J.
AU - Ring, Johannes
AU - Gelmetti, Carlo
AU - Kapp, Alexander
AU - Furue, Masutaka
AU - De Prost, Yves
AU - Darsow, Ulf
AU - Werfel, Thomas
AU - Atherton, David
AU - Oranje, Arnold P.
PY - 2006/2
Y1 - 2006/2
N2 - The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.
AB - The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.
UR - http://www.scopus.com/inward/record.url?scp=31944433906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31944433906&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2005.11.038
DO - 10.1016/j.jaci.2005.11.038
M3 - Article
C2 - 16514773
AN - SCOPUS:31944433906
SN - 0091-6749
VL - 117
SP - 378
EP - 390
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -